Torrent Pharma in talks to buy Unichem Lab’s domestic business: Report

30 Oct 2017 Evaluate

Torrent Pharma is reportedly in advanced discussion to buy Unichem Lab’s domestic business. The company’s domestic business generates revenue of around Rs 900 crore. For the domestic assets, the company is likely to offer Rs 3,250 crore. The deal may be announced next week if the talks fructify.

Currently, Unichem Lab is ranked 25th in the domestic market. The company’s operations are 57 percent of its sales and within the domestic business, chronic care business comprises 59 percent of the sales.

Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.

Torrent Pharma Share Price

4018.75 13.90 (0.35%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×